Related Experiment Video
Updated: Jun 7, 2026

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies
Published on: November 30, 2016
Extinction kinetics for metastatic cancer stem cells.
1Division of Radiation Oncology, The Ottawa Hospital Cancer Centre, The University of Ottawa, and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. wkendal@ottawahospital.on.ca
Cancer stem cells (CSCs) drive tumor growth. Understanding CSC dynamics, including their loss, reveals mechanisms for metastasis control and enhances cancer treatment effectiveness.
Area of Science:
- Mathematical modeling
- Cancer biology
- Tumorigenesis
Background:
- Cancer stem cells (CSCs) are crucial for tumor growth, self-renewal, and differentiation.
- The balance of CSC replication and loss influences metastatic potential and treatment outcomes.
Purpose of the Study:
- To develop a mathematical model for random gain and loss of metastatic CSCs.
- To investigate how CSC dynamics affect metastatic efficiency, tumor involution, and treatment response.
Main Methods:
- A stochastic birth-death model was employed to simulate CSC replication and loss.
- The model incorporated single and sequential cancer treatments, including CSC repopulation dynamics.
Main Results:
- Metastasis extinction occurs when CSC loss exceeds gains, with extinction probability highest during stochastic susceptibility periods.
- Cancer treatments can extend or reestablish these periods of susceptibility.
Conclusions:
- Random CSC loss, coupled with 'seed and soil' principles, explains metastatic inefficiency and tumor involution.
- Protracted susceptibility periods offer therapeutic windows, with high CSC loss correlating to better treatment response.
- Modulating CSC loss can significantly improve conventional cancer therapy efficacy.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers

